Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 2021 / Cilt: 74 - Sayı: 1

Relationship to Chronic Inflammation and Microbiota in Individuals with HIV

HIV ile Yaşayan Bireylerde Kronik Enflamasyon ve Mikrobiyota İlişkisi

Pages
10–16
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, the causes and mechanism of chronic inflammation seen in HIV infection and the effect of microbiota dysbiosis will be evaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although viral replication has been reduced to undetectable levels with antiretroviral treatment in human immunodeficiency virus (HIV) infection, chronic persistent inflammation associated with the progression of the disease is known to persist throughout life.
📊
Key Findings & Data:Inflammation is a response created by the immune system to repair damaged tissues, and the slow progress of this response and its continuation for a long time is called chronic inflammation.
💡
Conclusion & Impact:In this article, the causes and mechanism of chronic inflammation seen in HIV infection and the effect of microbiota dysbiosis will be evaluated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Although viral replication has been reduced to undetectable levels with antiretroviral treatment in human immunodeficiency virus (HIV) infection, chronic persistent inflammation associated with the progression of the disease is known to persist throughout life. Inflammation is a response created by the immune system to repair damaged tissues, and the slow progress of this response and its continuation for a long time is called chronic inflammation. Many studies have shown that microbiota dysbiosis and microbial translocation play an important role in the pathogenesis of inflammation in individuals living with HIV. The ongoing chronic inflammation and microbiota relationship and therapeutic intervention studies aiming at changing the microbiota are a relatively newly researched area in the treatment of HIV infection, and advances in this area show promise in preventing HIV infection’s long-term damage to the human body. In this article, the causes and mechanism of chronic inflammation seen in HIV infection and the effect of microbiota dysbiosis will be evaluated.

Özet

İnsan immün yetmezlik virüsü (HIV) enfeksiyonunda antiretroviral tedavi ile viral replikasyon tespit edilemeyen düzeylere indirilmiş olsa da, hastalığının ilerlemesi ile ilişkili kronik persistan enflamasyonun ömür boyu devam ettiği bilinmektedir. Enflamasyon, immün sistemin hasarlı dokuları onarmak için oluşturduğu bir tepki olup bu yanıtın yavaş ilerleyip uzun süre devam etmesi kronik enflamasyon olarak adlandırılır. Birçok çalışmada HIV ile yaşayan bireylerde mikrobiyota disbiyozu ve mikrobiyal translokasyonun enflamasyon patogenezinde önemli rol oynadığı gösterilmiştir. Devam eden kronik enflamasyon ve mikrobiyota ilişkisinin daha net bir şekilde ortaya konulması ve beraberinde mikrobiyotayı değiştirme amaçlı terapötik müdahale çalışmaları HIV enfeksiyonu tedavisinde nispeten yeni araştırılan bir alandır ve bu alandaki gelişmeler HIV enfeksiyonunun insan vücudu üzerindeki uzun dönem hasarlarının önlenmesinde umut vadetmektedir. Bu yazıda HIV enfeksiyonunda görülen kronik enflamasyon nedenleri ve mekanizması, mikrobiyata disbiyozunun etkisi değerlendirilecektir.

🔖

Cite This Article

BİLGİÇ, Z., KAYAASLAN, B. (2022). Relationship to Chronic Inflammation and Microbiota in Individuals with HIV. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 74 - Sayı: 1, 10–16. https://ajindex.com/articles/443459

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kaur US, Shet A, Rajnala N, et al. High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy. Sci Rep. 2018;8:17679
  2. Herrera S, Martínez-Sanz J, Serrano-Villar S. HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases. Front Immunol. 2019;10:1466
  3. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013;39:633-645
  4. Kuralay F, Çavdar Z. İnflamatuar medyatörlere toplu bir bakış. Genel Tıp Derg. 2006;16:143-152
  5. Highleyman L. Inflammation, immune activation, and HIV. BETA. 2010;22:12-26
  6. Stacey AR, Norris PJ, Qin L, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009;83:3719-3733
  7. Chevalier MF, Petitjean G, Dunyach-Rémy C, et al. The Th17/Treg ratio, IL- 1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation. PLoS Pathog. 2013;9:e1003453
  8. Doisne JM, Urrutia A, Lacabaratz-Porret C, et al. CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol. 2004;173:2410-2418
  9. Hsue PY, Waters DD. HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol. 2019;16:745-759
  10. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371
  11. Highleyman L. Inflammation, immune activation, and HIV. BETA. 2010;22:12-26
  12. Neuhaus J, Jacobs DR Jr, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV inefction. J Infect Dis. 2010;201:1788-1795
  13. Burdo TH, Lo J, Abbara S, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011;204:1227-1236
  14. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203:780-790
  15. Brenchley JM, Paiardini M, Knox KS, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood. 2008;112:2826-2835
  16. Favre D, Mold